142 related articles for article (PubMed ID: 12502928)
1. Expression of FKBP12 in benign and malignant vascular endothelium: an immunohistochemical study on conventional sections and tissue microarrays.
Higgins JP; Montgomery K; Wang L; Domanay E; Warnke RA; Brooks JD; van de Rijn M
Am J Surg Pathol; 2003 Jan; 27(1):58-64. PubMed ID: 12502928
[TBL] [Abstract][Full Text] [Related]
2. Expression of Fli-1, a nuclear transcription factor, distinguishes vascular neoplasms from potential mimics.
Folpe AL; Chand EM; Goldblum JR; Weiss SW
Am J Surg Pathol; 2001 Aug; 25(8):1061-6. PubMed ID: 11474291
[TBL] [Abstract][Full Text] [Related]
3. Vascular endothelial growth factor receptor-3 (VEGFR-3): a marker of vascular tumors with presumed lymphatic differentiation, including Kaposi's sarcoma, kaposiform and Dabska-type hemangioendotheliomas, and a subset of angiosarcomas.
Folpe AL; Veikkola T; Valtola R; Weiss SW
Mod Pathol; 2000 Feb; 13(2):180-5. PubMed ID: 10697276
[TBL] [Abstract][Full Text] [Related]
4. Effectiveness of Vascular Markers (Immunohistochemical Stains) in Soft Tissue Sarcomas.
Naeem N; Mushtaq S; Akhter N; Hussain M; Hassan U
J Coll Physicians Surg Pak; 2018 May; 28(5):352-356. PubMed ID: 29690962
[TBL] [Abstract][Full Text] [Related]
5. Angiosarcomas express mixed endothelial phenotypes of blood and lymphatic capillaries: podoplanin as a specific marker for lymphatic endothelium.
Breiteneder-Geleff S; Soleiman A; Kowalski H; Horvat R; Amann G; Kriehuber E; Diem K; Weninger W; Tschachler E; Alitalo K; Kerjaschki D
Am J Pathol; 1999 Feb; 154(2):385-94. PubMed ID: 10027397
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of anti-thrombomodulin antibody as a tumor marker for vascular neoplasms.
Manning T; Smoller BR; Horn TD; El Darouti M; Marzouk S; Hadidi HE; Ramadan S
J Cutan Pathol; 2004 Nov; 31(10):652-6. PubMed ID: 15491324
[TBL] [Abstract][Full Text] [Related]
7. Expression of a lymphatic endothelial cell marker in benign and malignant vascular tumors.
Xu H; Edwards JR; Espinosa O; Banerji S; Jackson DG; Athanasou NA
Hum Pathol; 2004 Jul; 35(7):857-61. PubMed ID: 15257549
[TBL] [Abstract][Full Text] [Related]
8. [Characteristics of ERG, Fli-1, CD34, CD31 and Fâ…§RAg expression in hepatic malignant vascular tumors].
Wang ZB; An XJ; Deng JF; Liu JH; Shi HY
Zhonghua Bing Li Xue Za Zhi; 2017 Nov; 46(11):760-763. PubMed ID: 29136688
[No Abstract] [Full Text] [Related]
9. On the discriminatory value of anti-HPCA-1 (CD-34) in the differential diagnosis of benign and malignant cutaneous vascular proliferations.
Suster S; Wong TY
Am J Dermatopathol; 1994 Aug; 16(4):355-63. PubMed ID: 7526723
[TBL] [Abstract][Full Text] [Related]
10. CD31 expression in intratumoral macrophages: a potential diagnostic pitfall.
McKenney JK; Weiss SW; Folpe AL
Am J Surg Pathol; 2001 Sep; 25(9):1167-73. PubMed ID: 11688576
[TBL] [Abstract][Full Text] [Related]
11. Epithelioid sarcoma-like hemangioendothelioma.
Billings SD; Folpe AL; Weiss SW
Am J Surg Pathol; 2003 Jan; 27(1):48-57. PubMed ID: 12502927
[TBL] [Abstract][Full Text] [Related]
12. Monoclonal antibody D2-40, a new marker of lymphatic endothelium, reacts with Kaposi's sarcoma and a subset of angiosarcomas.
Kahn HJ; Bailey D; Marks A
Mod Pathol; 2002 Apr; 15(4):434-40. PubMed ID: 11950918
[TBL] [Abstract][Full Text] [Related]
13. KIT expression in angiosarcomas and fetal endothelial cells: lack of mutations of exon 11 and exon 17 of C-kit.
Miettinen M; Sarlomo-Rikala M; Lasota J
Mod Pathol; 2000 May; 13(5):536-41. PubMed ID: 10824925
[TBL] [Abstract][Full Text] [Related]
14. Angiostatin receptor annexin II in vascular tumors including angiosarcoma.
Syed SP; Martin AM; Haupt HM; Arenas-Elliot CP; Brooks JJ
Hum Pathol; 2007 Mar; 38(3):508-13. PubMed ID: 17239928
[TBL] [Abstract][Full Text] [Related]
15. Prox1 transcription factor as a marker for vascular tumors-evaluation of 314 vascular endothelial and 1086 nonvascular tumors.
Miettinen M; Wang ZF
Am J Surg Pathol; 2012 Mar; 36(3):351-9. PubMed ID: 22067331
[TBL] [Abstract][Full Text] [Related]
16. Growth hormone in vascular pathology: neovascularization and expression of receptors is associated with cellular proliferation.
Lincoln DT; Singal PK; Al-Banaw A
Anticancer Res; 2007; 27(6B):4201-18. PubMed ID: 18225592
[TBL] [Abstract][Full Text] [Related]
17. Podoplanin is a useful diagnostic marker for epithelioid hemangioendothelioma of the liver.
Fujii T; Zen Y; Sato Y; Sasaki M; Enomae M; Minato H; Masuda S; Uehara T; Katsuyama T; Nakanuma Y
Mod Pathol; 2008 Feb; 21(2):125-30. PubMed ID: 18084256
[TBL] [Abstract][Full Text] [Related]
18. Immunohistochemical Analysis of Endothelial Cells in Vascular Transformation of Lymph Node Sinuses: Vascular or Lymphatic Differentiation?
Basha BM; Hsi ED
Appl Immunohistochem Mol Morphol; 2019 Jul; 27(6):482-489. PubMed ID: 29629951
[TBL] [Abstract][Full Text] [Related]
19. Differential expression of active mitogen-activated protein kinase in cutaneous endothelial neoplasms: implications for biologic behavior and response to therapy.
Arbiser JL; Weiss SW; Arbiser ZK; Bravo F; Govindajaran B; Caceres-Rios H; Cotsonis G; Recavarren S; Swerlick RA; Cohen C
J Am Acad Dermatol; 2001 Feb; 44(2):193-7. PubMed ID: 11174372
[TBL] [Abstract][Full Text] [Related]
20. Cutaneous vascular proliferations. Part III. Malignant neoplasms, other cutaneous neoplasms with significant vascular component, and disorders erroneously considered as vascular neoplasms.
Requena L; Sangueza OP
J Am Acad Dermatol; 1998 Feb; 38(2 Pt 1):143-75; quiz 176-8. PubMed ID: 9486670
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]